ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02670083
Brief Title: CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

First Submitted : January 28, 2016
First Submitted that Met QC Criteria : January 28, 2016
First Posted : February 1, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 8, 2018
Last Update Posted : August 10, 2018